Related Experiment Video
Updated: Jul 27, 2026
13:03
Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues
Published on: June 3, 2016
Directed differentiation of embryonic stem cells: genetic and epigenetic methods
1Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0616, USA. oshea@umich.edu
Summary
Embryonic stem cells offer great therapeutic potential but differentiating them into specific cell types remains challenging. Recent advances focus on growth factor manipulation and genetic engineering to improve lineage-restricted differentiation.
Area of Science:
- Developmental Biology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Embryonic stem cells (ESCs) originate from the blastocyst's inner cell mass.
- ESCs possess self-renewal and pluripotency, differentiating into all cell types.
- ESCs are valuable for developmental studies and therapeutic applications.
Purpose of the Study:
- To review recent advancements in directing ESC differentiation towards specific lineages.
- To discuss methods involving growth factor manipulation and genetic engineering.
- To highlight challenges and concerns associated with therapeutic ESC applications.
Main Methods:
- Summarizing recent scientific literature on ESC differentiation.
- Focusing on two primary approaches: growth factor manipulation and genetic alteration.
- Analyzing the risks and benefits associated with each method.
Main Results:
- Growth factor manipulation and genetic engineering show promise in promoting lineage-restricted differentiation.
- Genetic alterations may yield purer cell populations but carry risks of malignant transformation.
- Epigenetic methods can be incomplete, risking teratoma formation from residual pluripotent cells.
Conclusions:
- Precise control over ESC differentiation is crucial for therapeutic applications.
- Further understanding of developmental lineage specification is needed.
- Balancing therapeutic potential with safety concerns is paramount for clinical translation.
More Related Videos
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:24Methods of Nuclear Reprogramming
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for injury repair.